643: Letrozole (FEMARA®), a new potent, selective aromatase inhibitor (AI): Superior to another AI, aminoglutethimlde (AG), in postmenopausal women with advanced breast cancer (ABC), after relapse or progression on previous anti-estrogen therapy
- 30 September 1997
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 33, S145
- https://doi.org/10.1016/s0959-8049(97)85215-x
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: